583 related articles for article (PubMed ID: 18948690)
1. Correlation of gut hormones with irritable bowel syndrome.
Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
[TBL] [Abstract][Full Text] [Related]
2. Proximal and distal gut hormone secretion in irritable bowel syndrome.
Van Der Veek PP; Biemond I; Masclee AA
Scand J Gastroenterol; 2006 Feb; 41(2):170-7. PubMed ID: 16484122
[TBL] [Abstract][Full Text] [Related]
3. [Role of gut hormones in irritable bowel syndrome].
Morise K; Furusawa A; Yamamoto H; Saito H
Nihon Rinsho; 1992 Nov; 50(11):2697-702. PubMed ID: 1287245
[TBL] [Abstract][Full Text] [Related]
4. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin octapeptide (CCK-8) concentration in plasma is not affected in functional abdominal pain in children.
Uścinowicz M; Kaczmarski M
Rocz Akad Med Bialymst; 2005; 50():257-60. PubMed ID: 16358979
[TBL] [Abstract][Full Text] [Related]
6. [Small intestine motility and gastrointestinal hormone levels in irritable bowel syndrome].
Zhao JH; Dong L; Hao XQ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1492-5. PubMed ID: 17959521
[TBL] [Abstract][Full Text] [Related]
7. Sigmoid-colonic motility in health and irritable bowel syndrome: a role for 5-hydroxytryptamine.
Houghton LA; Atkinson W; Lockhart C; Whorwell PJ; Keevil B
Neurogastroenterol Motil; 2007 Sep; 19(9):724-31. PubMed ID: 17539895
[TBL] [Abstract][Full Text] [Related]
8. [Irritable bowel syndrome with extraintestinal manifestations from a position of neuroendocrine pathology].
Osadchuk MA; Burdina VO
Eksp Klin Gastroenterol; 2015; (2):29-34. PubMed ID: 25993870
[TBL] [Abstract][Full Text] [Related]
9. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
Atkinson W; Lockhart S; Whorwell PJ; Keevil B; Houghton LA
Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
[TBL] [Abstract][Full Text] [Related]
10. 5-hydroxytryptamine signalling in irritable bowel syndrome with diarrhoea: effects of gender and menstrual status.
Houghton LA; Brown H; Atkinson W; Morris J; Fell C; Whorwell PJ; Lockhart S; Keevil B
Aliment Pharmacol Ther; 2009 Nov; 30(9):919-29. PubMed ID: 19691669
[TBL] [Abstract][Full Text] [Related]
11. [A correlation study between diarrhea-predominant irritable bowel syndrome complicated functional dyspepsia patients of Gan-stagnation Pi-deficiency syndrome and gastrointestinal hormones].
Zhao L; Song W; Zhu P; Zhang Y; Bu P
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1168-72. PubMed ID: 25509256
[TBL] [Abstract][Full Text] [Related]
12. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity.
Gonlachanvit S; Mahayosnond A; Kullavanijaya P
Neurogastroenterol Motil; 2009 Jan; 21(1):23-32. PubMed ID: 18647268
[TBL] [Abstract][Full Text] [Related]
13. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.
Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Sim J; Jang KS
Scand J Gastroenterol; 2014 Jan; 49(1):43-51. PubMed ID: 24256141
[TBL] [Abstract][Full Text] [Related]
14. Alternation of substance P-containing neural pathways in a rat model of irritable bowel syndrome with rectal distension.
Wang WF; Yang YS; Peng LH; Sun G
Chin J Dig Dis; 2006; 7(4):211-8. PubMed ID: 17054583
[TBL] [Abstract][Full Text] [Related]
15. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
[TBL] [Abstract][Full Text] [Related]
17. Peripheral factors in the pathophysiology of irritable bowel syndrome.
Gunnarsson J; Simrén M
Dig Liver Dis; 2009 Nov; 41(11):788-93. PubMed ID: 19665956
[TBL] [Abstract][Full Text] [Related]
18. Postprandial effect of gastrointestinal hormones and gastric activity in patients with irritable bowel syndrome.
Furgała A; Ciesielczyk K; Przybylska-Feluś M; Jabłoński K; Gil K; Zwolińska-Wcisło M
Sci Rep; 2023 Jun; 13(1):9420. PubMed ID: 37296188
[TBL] [Abstract][Full Text] [Related]
19. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.
Koszycki D; Torres S; Swain JE; Bradwejn J
Psychosom Med; 2005; 67(4):590-5. PubMed ID: 16046372
[TBL] [Abstract][Full Text] [Related]
20. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
